Pneumotox » Drug » Arsenic trioxide (As2O3)

Arsenic trioxide (As2O3)

3

See also under ATRA

Last update : 03/06/2013

I.b Pneumonitis (ILD)

1

II.a Pulmonary edema, noncardiogenic (NCPE)

2

II.b ARDS - Acute lung injury

2

II.k Pulmonary edema/ARDS of the ATRA syndrome (see Xab)

1

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

2

V.a Pleural effusion (uni- or bilateral) (May commpany ILDs)

1

X.r Fluid retention

1

X.ab The differentiation- or ATRA syndrome

1

XII.c Pericardial effusion (w/wo tamponade)

1

XII.ai Cardiotoxicity

1

Diagnosing DIRD

1

Drug and radiation history

2

Drug singularity - Correct identification of the drug

3

Consistent timing of exposure v. onset of symptoms

4

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

5

Careful exlusion of another cause

6

Remission of symptoms with removal of drug

7

Recurrence with rechallenge (rarely advisable)

8

Causality assessment

More detailed checklist